Sonic Incytes_Secondary_Colour

Sonic Incytes Medical Corp. is the developer of VelacurTM – the first handheld 3D liver health assessment solution. Cleared by the FDA, VelacurTM is a breakthrough, non-invasive imaging test that quantifies liver elasticity and attenuation with reliability and accuracy comparable to MRI. VelacurTM offers providers a fast, accurate and practical way to measure a patient’s liver health and grow their practice. In addition, it is a cost-effective tool for pharma to screen patients for NASH clinical trials and monitor therapeutic effectiveness of promising NASH drugs.

Request a private demo at www.velacur.com or learn more at www.sonicincytes.com

Team Members

George

George Aliphtiras

Chief Executive Officer

Caitlin

Caitlin Schneider, PhD

Lead, Clinical Engineer

Stephen

Dr. Stephen Harrison

Medical Director for Pinnacle Clinical Research and the President of Summit Clinical Research

Angela

Angela Koulyras

Director, Marketing & Communications